Technology | May 07, 2008

IV Catheter Designed to Lower Exposure

A safety engineered short-term peripheral intravenous (IV) catheter, the VantageCath, is designed to reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets.

Existing safety engineered peripheral IVs have mechanisms to protect the needle that has been contaminated, but do not usually address the problem of blood leaking out of an open hub. The VantageCath by Advantage Medical Devices utilizes a closed-hub system that reportedly eliminates the need to tamponade above the site while connecting tubing or saline lock.

The VantageCath comes with built in, needle-free access to empower the clinician with primary needle stick injury prevention and can immediately be used to deliver push meds, connect to an extension tubing or standard IV or pump tubing. The VantageCath utilizes a push button retraction mechanism for shielding the used needle that is similar to existing devices to minimize the learning curve for clinicians and has been well received by nurses, paramedics, and physicians who used the device during the Simulated Clinical Use study.


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now